Skip to main content

Stunning facts about diabetes history....



The ancient Egyptians first described diabetes around 1500 BC.  It was described as a condition in which a person urinated excessively and lost weight.
The urine of diabetics was noted to be copious and sweet.  The Greek physician Aretaeus (80-138 C.E.) noted that the syndrome manifested as polyuria, and used the term, διαβήτης (diabetes), which means “a siphon, a passer through.”
In 1675, the English physician Thomas Willis added “mellitus” to the designation when he noticed that the urine of diabetics had a sweet odor.  Mellitus comes from the Latin root for “honey.”
Matthew Dobson documented elevated glucose levels in the urine of diabetics in 1776.
In 1889, Joseph von Mering and Oskar Minkowski found that removing the pancreas from dogs resulted in fatal diabetes.  This provided the first clue that the pancreas plays a key role in regulating glucose concentrations.
In 1910, Edward Albert Sharpey-Schafer hypothesized that diabetes was due to the deficiency of a chemical excreted by the pancreas.  He named this chemical “insulin”, from the Latin word insula, meaning island in reference to the pancreatic islet cells of Langerhans.
In 1921, Frederick Banting and Charles Best discovered insulin.  The researchers obtained extract from pancreatic islet cells of healthy dogs and administered it to diabetic dogs.  In doing so, they were able to reverse the diabetes.
Fifteen years after the discovery of insulin, in 1936, Harold Himsworth proposed the idea that many patients with diabetes may have insulin resistance rather than insulin deficiency.
From 1923 to 2012, only ten scientists have received the Nobel Prize for diabetes research.
The prevalence of diabetes has increased worldwide.  In the U.S. alone, the number of diabetes cases has increased during the time period of 1980 to 2010.  In 1980, there were 5.6 million people in the U.S. with diabetes.  In to 2010, there were 20.9 million people in the U.S. with diabetes.  (This represents 2.5% and 6.9% of the population, respectively.)  At this rate, 1 in 3 U.S. adults could have diabetes by 2050.

Comments

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...

Things to Avoid in Anesthesia for Pregnant with Pulmonary hypertension

Anesthesia for Pregnant woman with Pulmonary Hypertension is a real challenge for anesthesiologist. It is very crucial to remember the pathophysiology of pulmonary hypertension in pregnant women and to avoid some practices that will worsen the cardiac status. 1-Avoid single shot spinal anesthesia. Some authorities consider pulmonary hypertension as absolute contraindication for single shot spinal anesthesia specially in patients with NYHA III ,IV. Spinal anesthesia causes major hemodynamic instability(decrease SVR, decrease VR, decrease in CO) The preferred neuroaxial techniques are (epidural anesthesia and CSE with minimal spinal dose) 2-Avoid PAC. Pulmonary Artery catheters insertion may lead to pulmonary artery rupture or thrombosis. TEE is better cardiac monitor/Arteial line is mandatory. 3-Avoid Nitrous oxide in gas mixture.N2O increase the PVR 4-If MV to be started, avoid High TV and PEEP 5-Avoid Oxytocin Boluses, or rapid administration of Pitocin. Oxytocin causes ...